Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population

Status unconfirmed · Not applicable

Conditions studied: Liver Diseases, Alcoholic

In brief

This is a pilot study examining whether an evidence-based recovery support smartphone application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver disease (ALD).

Key facts

Study ID

NCT03388320

Run by

New York Presbyterian Hospital

People needed

30

Starts

2018-04-24

Expected to finish

2021-12-01

Last updated by the study team

2019-03-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Alcoholic liver disease
• Followed or seen at New York Presbyterian Hospital / Weill Cornell Medical Center
• English speaking
• Access to a smartphone

You may not qualify if…

• Unable to consent
• Primary language other than English
• No access to a smartphone

Where it is running

• New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.